| XYTOS ANNOUNCES PUBLIC LISTING, TRADING SECTOR, AND FUTURE OF COMPANY. |
|
XYTOS, INC. NEWS RELEASE Trading Symbol: XYTS FOR IMMEDIATE DISSEMINATION XYTOS ANNOUNCES PUBLIC LISTING, TRADING SECTOR, AND FUTURE OF COMPANY. August 29, 2005 - Indianapolis, IN - XYTOS, Inc. (the "Company") (NASDAQ OTC Trading Symbol: (XYTS) is pleased to announce their public listing under the trading symbol of XYTS. XYTOS will trade in the Bio-Medical Sector, with the goal to accelerate the future of the "Science of Medicine" by introducing next generation Bio-Medical Technologies in the areas of Stem Cell Therapies, Cellular Medicine And Tissue Engineering. XYTOS will be announcing their Bio-Medical Technologies in the near future as well as a number of strategic relationships worldwide. Additionally XYTOS will soon be announcing Board Members from the Business and Medical Community. The XYTOS Website (www.xytos.com) is currently under construction and upon completion it will give the reader a more in-depth look into the future of XYTOS. Please note that XYTOS is in no way involved in techniques or procedures relating to embryonic stem cells or related tissues. The XYTOS Research and Development process is based on the use of Adult Stem Cells. These cells are found in mature tissue and are formed by the body to replace worn out cells in tissues and organs. Tim Cook, Chairman and CEO of XYTOS, Inc., commented, "We are truly excited about the future of XYTOS. We have worked for many years positioning this company to become a global leader on the forefront of the next generation of Medicine. We have quietly worked on our research and development for the past several years and we are now ready to introduce to the world next generation Bio-Medical Technologies in specific areas to be announced'. About XYTOS, Inc. XYTOS is a Bio-Medical Technologies Company concentrating on Next Generation Medicine and Medical Procedures in the areas of Stem Cell Therapies, Cellular Medicine and Tissue Engineering. Forward-Looking and Cautionary Statements: Certain statements contained herein, including, without limitation, statements containing the words "believes", "intends" and other words of similar import, constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of XYTOS, Inc. to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. XYTOS, Inc. disclaims any obligation to update or to announce publicly the results of any revision of the forward-looking statements contained or incorporated by reference herein to reflect future events or developments. Source: XYTOS, Inc. On behalf of the Board of Directors of: XYTOS INC. Tim Cook, CEO (Contact: investorrelations@xytos.com)
|